| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0959-4388(95)80072-7 |
| P698 | PubMed publication ID | 8580718 |
| P50 | author | James F. Gusella | Q1602688 |
| P2093 | author name string | MacDonald ME | |
| P433 | issue | 5 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 656-662 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Current Opinion in Neurobiology | Q15763572 |
| P1476 | title | Huntington's disease: CAG genetics expands neurobiology | |
| P478 | volume | 5 |
| Q45303890 | A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion |
| Q34287719 | Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease |
| Q24317096 | Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats |
| Q90327915 | Cortical Axonal Secretion of BDNF in the Striatum Is Disrupted in the Mutant-huntingtin Knock-in Mouse Model of Huntington's Disease |
| Q36941187 | Detection of Huntington's disease decades before diagnosis: the Predict-HD study |
| Q36753589 | Does the Mutant CAG Expansion in Huntingtin mRNA Interfere with Exonucleolytic Cleavage of its First Exon? |
| Q34061672 | Evaluation of CAG repeat length of androgen receptor expressing cells in human testes showing different pictures of spermatogenic impairment |
| Q34492842 | Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. |
| Q41087697 | Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease |
| Q41235542 | Huntington's disease: translating a CAG repeat into a pathogenic mechanism |
| Q21144448 | Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans |
| Q45299979 | Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. |
| Q41737191 | Molecular neurobiology and genetics: investigation of neural function and dysfunction |
| Q34208531 | Nitric oxide and nitric oxide synthase in Huntington's disease |
| Q35746858 | Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans |
| Q60938894 | Polyglutamine toxicity assays highlight the advantages of mScarlet for imaging in |
| Q45296540 | Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. |
| Q34797015 | Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron |
| Q43450643 | Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank |
| Q36368045 | Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. |
| Q33966800 | Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. |
| Q22306301 | The genetic epidemiology of neurodegenerative disease |
| Q38253642 | Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases |
Search more.